Brendan S Crabb Selected Research

N-(3-pyridyl)-3-phenylsuccinimide

1/2021	Characterisation of complexes formed by parasite proteins exported into the host cell compartment of Plasmodium falciparum infected red blood cells.
11/2016	Identification of inhibitors that dually target the new permeability pathway and dihydroorotate dehydrogenase in the blood stage of Plasmodium falciparum.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Brendan S Crabb Research Topics

Disease

65	Malaria 01/2021 - 12/2002
22	Infections 01/2021 - 12/2002
4	Parasitemia 04/2016 - 09/2003
3	Falciparum Malaria (Plasmodium falciparum Malaria) 01/2018 - 01/2012
2	Inflammation (Inflammations) 10/2016 - 04/2009
2	Cerebral Malaria 09/2013 - 04/2009
1	Neglected Diseases 01/2020
1	Starvation 11/2016
1	Vivax Malaria 12/2007
1	Persistent Infection 10/2007
1	Parasitic Diseases (Parasitic Disease) 11/2003

Drug/Important Bio-Agent (IBA)

22	Proteins (Proteins, Gene)FDA Link 01/2021 - 07/2006
17	AntibodiesIBA 01/2019 - 12/2002
16	AntigensIBA 01/2017 - 09/2003
13	VaccinesIBA 11/2020 - 12/2002
7	LigandsIBA 01/2018 - 02/2006
7	Membrane Proteins (Integral Membrane Proteins)IBA 12/2008 - 10/2004
6	Antimalarials (Antimalarial Agents)IBA 01/2020 - 05/2007
6	Merozoite Surface Protein 1 (MSA1)IBA 01/2016 - 09/2003
4	Malaria VaccinesIBA 01/2017 - 07/2004
4	Immunoglobulin G (IgG)IBA 01/2016 - 07/2004
4	EnzymesIBA 10/2008 - 12/2002
3	Pharmaceutical PreparationsIBA 01/2017 - 11/2003
3	Serine (L-Serine)FDA Link 09/2008 - 11/2003
2	N-(3-pyridyl)-3-phenylsuccinimideIBA 01/2021 - 11/2016
2	MacrolidesIBA 01/2021 - 07/2015
2	EpitopesIBA 01/2019 - 06/2003
2	Biomarkers (Surrogate Marker)IBA 01/2016 - 07/2013
1	rebemideIBA 01/2020
1	Neutralizing AntibodiesIBA 01/2019
1	Carrier Proteins (Binding Protein)IBA 01/2019
1	plasmepsin (plasmepsin I)IBA 01/2018
1	CD40 Ligand (CD40L)IBA 12/2017
1	Complement Factor H (Factor H)IBA 02/2016
1	Complement System Proteins (Complement)IBA 02/2016
1	Surface Antigens (Surface Antigen)IBA 01/2016
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 01/2016
1	Anti-Bacterial Agents (Antibiotics)IBA 07/2015
1	Azithromycin (Zithromax)FDA LinkGeneric 07/2015
1	NexusIBA 07/2014
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 05/2014
1	ThioredoxinsIBA 09/2013
1	Interleukin-12 (IL 12)IBA 02/2013
1	Tacrolimus Binding Proteins (FKBP)IBA 01/2012
1	Combined VaccinesIBA 11/2011
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 06/2010
1	Aspartic Acid ProteasesIBA 02/2010
1	RNA (Ribonucleic Acid)IBA 06/2009
1	SpectrinIBA 04/2009
1	Chemokine ReceptorsIBA 04/2009
1	ChemokinesIBA 04/2009
1	ImmunosorbentsIBA 10/2008
1	PapainIBA 09/2008
1	Cyclic PeptidesIBA 09/2008
1	Cysteine Proteases (Cysteine Protease)IBA 09/2008
1	Cysteine (L-Cysteine)FDA Link 12/2007
1	Plasmodium falciparum erythrocyte membrane protein 1IBA 10/2007
1	Indicators and Reagents (Reagents)IBA 05/2007
1	SolutionsIBA 05/2007
1	CytokinesIBA 11/2006
1	Chondroitin Sulfates (Chondroitin Sulfate)IBA 08/2006
1	Glycosylphosphatidylinositols (Glycosyl-Phosphatidylinositol)IBA 07/2006
1	Toll-Like Receptors (Toll-Like Receptor)IBA 02/2006
1	Antiviral Agents (Antivirals)IBA 02/2006
1	Pyruvate Dehydrogenase Complex (Dehydrogenase Complex, Pyruvate)IBA 01/2005
1	Biological ProductsIBA 12/2004
1	ColicinsIBA 11/2004
1	aerobactinIBA 11/2004
1	IronIBA 11/2004
1	Monoclonal AntibodiesIBA 10/2004
1	Plasmodium serine repeat antigenIBA 12/2002
1	Recombinant ProteinsIBA 12/2002
1	Peptide Hydrolases (Proteases)FDA Link 12/2002

Therapy/Procedure

1	Therapeutics 05/2007